Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinomaMasatoshi Kudo, Kiwamu Okita, Won Young Tak et al.|European Journal of Cancer|2011Cited by 573
Percutaneous Radiofrequency Ablation with Multiple Electrodes for Medium-Sized Hepatocellular CarcinomasJung Hyun Lee, Byung Ihn Choi, Jeong Min Lee et al.|Korean Journal of Radiology|2012Cited by 70
Modified AS1411 Aptamer Suppresses Hepatocellular Carcinoma by Up-Regulating Galectin-14Yuri Cho, Jung‐Hwan Yoon|PLoS ONE|2016Cited by 48
Ursodeoxycholic acid-induced inhibition of DLC1 protein degradation leads to suppression of hepatocellular carcinoma cell growthJung‐Hwan Yoon|Oncology Reports|2011Cited by 24
CKD-5, a novel pan-histone deacetylase inhibitor, synergistically enhances the efficacy of sorafenib for hepatocellular carcinomaYoung Woon Chang, Jung‐Hwan Yoon|BMC Cancer|2020Cited by 10